A Gram-positive, facultatively anaerobic bacterium that is the dominant species in the healthy human vaginal microbiome and a defining member of Community State Type I (CST-I). L. crispatus dominance is associated with reproductive health, pathogen resistance, and reduced risk of sexually transmitted infections. Its depletion marks a transition toward dysbiotic states linked to gynecological disease.
Vaginal Ecosystem Dominance
- L. crispatus maintains vaginal pH at 3.5-4.5 through vigorous production of D- and L-lactic acid, creating an environment hostile to most pathogenic bacteria and fungi.
- Produces hydrogen peroxide (H2O2), which directly kills or inhibits anaerobic pathogens including gardnerella-vaginalis and prevotella species.
- Adheres to vaginal epithelial cells via surface-layer proteins, competitively excluding pathogens from mucosal binding sites.
- CST-I (L. crispatus-dominant) communities show the lowest inflammatory cytokine profiles among all vaginal community state types, indicating active immune modulation rather than merely passive acidification.
Metal Dependencies and Iron Ecology
- L. crispatus has a low iron requirement compared to many pathogens, giving it a competitive advantage in iron-restricted environments.
- lactoferrin — the iron-binding glycoprotein abundant in cervicovaginal fluid — supports L. crispatus dominance by sequestering iron from iron-dependent pathogens while having minimal impact on Lactobacillus growth [1].
- This iron ecology represents a natural nutritional immunity mechanism: the host starves pathogens of iron while maintaining conditions favorable to L. crispatus.
- Manganese is an important cofactor for L. crispatus superoxide dismutase and other enzymes, providing oxidative stress protection without relying on iron-dependent systems.
Depletion in Gynecological Disease
The loss of L. crispatus dominance is a recurring finding across reproductive and gynecological conditions:
- Endometriosis: Vaginal microbiome profiles of endometriosis patients show reduced L. crispatus abundance and a shift toward mixed anaerobic communities. This shift correlates with increased inflammatory signaling and may contribute to disease progression [2].
- Ovarian cancer: L. crispatus is depleted in the reproductive tract microbiome of ovarian cancer patients, with potential diagnostic and prognostic significance [3].
- PCOS: Women with polycystic ovary syndrome and obesity show reduced vaginal Lactobacillus dominance, with phage-mediated lysis of L. crispatus proposed as a contributing mechanism [4].
- Tubal infertility: Chlamydia-associated tubal factor infertility correlates with loss of L. crispatus dominance and expansion of anaerobic pathobionts [5].
- Adenomyosis: Genital tract microbiota in adenomyosis patients shows reduced Lactobacillus dominance alongside altered intestinal microbiota, suggesting a genital-intestinal dysbiosis axis [6].
Relationship to the Estrobolome
- Vaginal L. crispatus abundance is influenced by estrogen status. Estrogen promotes glycogen deposition in vaginal epithelium, which L. crispatus ferments to lactic acid.
- Conditions that alter estrogen metabolism — including beta glucuronidase-mediated estrogen recirculation by gut bacteria — can indirectly affect vaginal Lactobacillus populations.
- This gut-vaginal axis connects the estrobolome concept to vaginal ecosystem health.
Cross-References
- lactobacillus — genus overview
- lactoferrin — iron-sequestering protein that supports L. crispatus dominance
- nutritional immunity — host metal restriction as pathogen control
- endometriosis — condition with L. crispatus depletion
- estrobolome — gut-estrogen-vaginal axis
- beta glucuronidase — enzyme linking gut and reproductive tract microbiomes